U.S. Markets closed
  • S&P Futures

    3,435.25
    -16.50 (-0.48%)
     
  • Dow Futures

    28,060.00
    -129.00 (-0.46%)
     
  • Nasdaq Futures

    11,623.50
    -40.00 (-0.34%)
     
  • Russell 2000 Futures

    1,623.50
    -12.10 (-0.74%)
     
  • Crude Oil

    39.30
    -0.55 (-1.38%)
     
  • Gold

    1,901.50
    -3.70 (-0.19%)
     
  • Silver

    24.46
    -0.22 (-0.87%)
     
  • EUR/USD

    1.1844
    -0.0024 (-0.2013%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3034
    -0.0004 (-0.0339%)
     
  • USD/JPY

    104.8400
    +0.1500 (+0.1433%)
     
  • BTC-USD

    13,099.02
    +78.12 (+0.60%)
     
  • CMC Crypto 200

    263.54
    +2.08 (+0.79%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,515.94
    -0.65 (-0.00%)
     

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Nano-X Imaging Ltd. and Encourages Investors to Contact the Firm Before November 16, 2020

KirMcInerney LLP
·2 mins read

NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) securities during the period from August 21, 2020 through September 15, 2020 (the “Class Period”). Investors have until November 16, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Nano-X’s commercial agreements and its customers were fabricated; (2) Nano-X’s statements regarding its “novel” Nano-X System were misleading as the Company never provided data comparing its images with images from competitors’ machines; (3) Nano-X’s submission to the U.S. Food and Drug Administration (“FDA”) admitted the Nano-X System was not original; and (4) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you acquired Nano-X securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, and whistleblower litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney’s website: www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq., (212) 371-6600
investigations@kmllp.com
www.kmllp.com